Ochsner Medical Center

About: Ochsner Medical Center is a healthcare organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 980 authors who have published 1159 publications receiving 49961 citations. The organization is also known as: Ochsner Hospital & Ochsner Foundation Hospital.

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer.

Abstract: The biological agents approved for the treatment of patients with metastatic colorectal cancer – bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor A, along with cetuximab and panitumumab, two monoclonal antibodies that target the epidermal growth factor receptor – are associated with a number of adverse events that range in severity from relatively mild to potentially life threatening. Hypertension, thromboembolic events, proteinuria, bleeding, and gastrointestinal perforation have all been associated with bevacizumab, while dermatologic toxicities are common with cetuximab and panitumumab. Hypersensitivity reactions and hypomagnesemia are also a concern with cetuximab and panitumumab. The frequency of these adverse events in randomized clinical trials is reviewed, and recommendations for managing these events in patients undergoing treatment for metastatic colorectal cancer are provided.

The S.T.A.B.L.E. Program: postresuscitation/pretransport stabilization care of sick infants.

Abstract: The S.T.A.B.L.E. Program is the first neonatal continuing education program to focus exclusively on the post-resuscitation/pre-transport stabilization care of sick infants. Neonatal Resuscitation Program provides the requisite education for healthcare providers to safely and systematically resuscitate neonates. However, those infants who require resuscitation also require ongoing care to decrease the risk of morbidity and mortality. The S.T.A.B.L.E. Program provides all members of the neonatal healthcare team with the knowledge needed to render necessary care to infants who are under post-resuscitation or pre-transport stabilization care. Utilizing an organized approach, the S.T.A.B.L.E. Program facilitates the care process by prompting healthcare providers to focus on specific areas of care. This article provides an overview of (1) the history of the S.T.A.B.L.E. Program, (2) the philosophy and goals of the program, (3) a course overview of individual modules, (4) acceptance and recognition of the program in the healthcare community, (5) the target audience, and (6) administration of the course.

Epstein-Barr Virus Infection in Desert Storm Reservists

Abstract: Approximately 150 U.S. Army reservists from Indiana reported symptoms consistent with chronic fatigue syndrome after returning stateside from the tour of duty in Saudi Arabia. A psychiatric team confirmed the diagnosis, evaluated possible etiology, and treated the service members when appropriate. Those available service members who met the study's diagnostic criteria for chronic fatigue syndrome (n = 37) received an Epstein-Barr virus panel. Seventy-three percent of these selected service members were positive either for an acute or reactivated Epstein-Barr viral infection. These data suggest that service members who suffer from chronic fatigue syndrome may have their symptoms increased and prolonged by secondary viral infections.

Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients.

Abstract: Background: Bronchiolitis obliterans syndrome (BOS) is the major limitation to long-term survival following lung transplantation and strategies to reduce its incidence have remained elusive. Macrolides may stabilize lung function in patients with established BOS. Their role, however, in prevention of BOS remains unexamined.